Avian influenza A H5N1 virus: a continuous threat to humans

References

• Yuen KY, Chan PK, Peiris M et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet1998; 351: 467–471.
   PubMed Web of Science ®Google Scholar
• Cheng VC, Chan JF, Wen X et al. Infection of immunocompromised patients by avian H9N2 influenza A virus. J Infect2011; 62: 394–399.
   PubMed Web of Science ®Google Scholar
• Banks J, Speidel E, Alexander DJ. Characterisation of an avian influenza A virus isolated from a human—is an intermediate host necessary for the emergence of pandemic influenza viruses? Arch Virol1998; 143: 781–787.
   PubMed Web of Science ®Google Scholar
• Editorial team. Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill2007; 12: E070531–E070532.
   Google Scholar
• Tweed SA, Skowronski DM, David ST et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis2004; 10: 2196–2199.
   PubMed Web of Science ®Google Scholar
• Arzey GG, Kirkland PD, Arzey KE et al. Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis2012; 18: 814–816.
   PubMed Web of Science ®Google Scholar
• Cheng VC, To KK, Tse H, Hung IF, Yuen KY. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev2012; 25: 223–263.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003–2012. Geneva: WHO, 2012. Available at http://www.who.int/influenza/human_animal_interface/EN_GIP_20120529CumulativeNumberH5N1cases.pdf (accessed 6 June 2012).
   Google Scholar
• Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med2008; 358: 261–273.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. Geneva: WHO, 2012. Available at http://www.who.int/influenza/vaccines/virus/201202_h5_h9_vaccinevirusupdate.pdf (accessed 6 June 2012).
   Google Scholar
• World Health Organization. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. Geneva: WHO, 2011. Available at http://www.who.int/influenza/resources/documents/2011_09_h5_h9_vaccinevirusupdate.pdf (accessed 6 June 2012).
   Google Scholar
• World Health Organization. Updated unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses. Geneva: WHO, 2011. Available at http://www.who.int/influenza/gisrs_laboratory/h5n1_nomenclature/en/index.html (accessed 6 June 2012).
   Google Scholar
• Fiebig L, Soyka J, Buda S, Buchholz U, Dehnert M, Haas W. Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010. Eur Surveill2011; 16: pii: 19941.
   Google Scholar
• Kayali G, El-Shesheny R, Kutkat MA et al. Continuing threat of influenza (H5N1) virus circulation in Egypt. Emerg Infect Dis2011; 17: 2306–2308.
   PubMed Web of Science ®Google Scholar
• Wang TT, Parides MK, Palese P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science2012; 335: 1463.
   PubMed Web of Science ®Google Scholar
• Murray EJ, Morse SS. Seasonal oscillation of human infection with influenza A/H5N1 in Egypt and Indonesia. PLoS ONE2011; 6: e24042.
   PubMed Web of Science ®Google Scholar
• To KK, Wong SS, Li IW et al. Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection. Postgrad Med J2010; 86: 515–521.
   PubMed Web of Science ®Google Scholar
• Zhang AJ, To KK, Tse H et al. High incidence of severe influenza among individuals over 50 years of age. Clin Vaccine Immunol2011; 18: 1918–1924.
   PubMedGoogle Scholar
• Rutigliano JA, Morris MY, Yue W et al. Protective memory responses are modulated by priming events prior to challenge. J Virol2010; 84: 1047–1056.
   PubMed Web of Science ®Google Scholar
• Liem NT, Tung CV, Hien ND et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004–2006. Clin Infect Dis2009; 48: 1639–1646.
   PubMed Web of Science ®Google Scholar
• Wan XF, Dong L, Lan Y et al. Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol2011; 85: 13432–13438.
   PubMed Web of Science ®Google Scholar
• Zhou L, Liao Q, Dong L et al. Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis2009; 199: 1726–1734.
   PubMed Web of Science ®Google Scholar
• Indriani R, Samaan G, Gultom A et al. Environmental sampling for avian influenza virus A (H5N1) in live-bird markets, Indonesia. Emerg Infect Dis2010; 16: 1889–1895.
   PubMed Web of Science ®Google Scholar
• Wang H, Feng Z, Shu Y et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet2008; 371: 1427–1434.
   PubMed Web of Science ®Google Scholar
• Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet2008; 371: 1464–1475.
   PubMed Web of Science ®Google Scholar
• Shinya K, Makino A, Tanaka H et al. Systemic dissemination of H5N1 influenza A viruses in ferrets and hamsters after direct intragastric inoculation. J Virol2011; 85: 4673–4678.
   PubMed Web of Science ®Google Scholar
• Harder TC, Teuffert J, Starick E et al. Highly pathogenic avian influenza virus (H5N1) in frozen duck carcasses, Germany, 2007. Emerg Infect Dis2009; 15: 272–279.
   PubMed Web of Science ®Google Scholar
• Imai M, Kawaoka Y. The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol2012; 2: 160–167.
   PubMed Web of Science ®Google Scholar
• Gabriel G, Klingel K, Otte A et al. Differential use of importin-alpha isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun2011; 2: 156.
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Manz B, Haller O, Schwemmle M, Kochs G. The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J Virol2011; 85: 8133–8140.
   PubMed Web of Science ®Google Scholar
• Miotto O, Heiny AT, Albrecht R et al. Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS ONE2010; 5: e9025.
   PubMed Web of Science ®Google Scholar
• Tong S, Li Y, Rivailler P et al. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci USA2012; 109: 4269–4274.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Ibrahim MS, Suzuki Y, Ikuta K. The changing nature of avian influenza A virus (H5N1). Trends Microbiol2012; 20: 11–20.
   PubMed Web of Science ®Google Scholar
• Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol2005; 3: 591–600.
   PubMed Web of Science ®Google Scholar
• WHO/OIE/FAO H5N1 Evolution Working Group. Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respi Viruses2012; 6: 1–5.
   PubMed Web of Science ®Google Scholar
• Buchy P, Fourment M, Mardy S et al. Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina peninsula, 2004–2007. Emerg Infect Dis2009; 15: 1641–1644.
   PubMed Web of Science ®Google Scholar
• Dung Nguyen T, Vinh Nguyen T, Vijaykrishna D et al. Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005–2007. Emerg Infect Dis2008; 14: 632–636.
   PubMed Web of Science ®Google Scholar
• Suwannakarn K, Amonsin A, Sasipreeyajan J et al. Molecular evolution of H5N1 in Thailand between 2004 and 2008. Infect Genet Evol2009; 9: 896–902.
   PubMed Web of Science ®Google Scholar
• Buchy P, Mardy S, Vong S et al. Influenza A/H5N1 virus infection in humans in Cambodia. J Clin Virol2007; 39: 164–168.
   PubMed Web of Science ®Google Scholar
• Le QM, Ito M, Muramoto Y et al. Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam. J Gen Virol2010; 91( Pt 10): 2485–2490.
   PubMed Web of Science ®Google Scholar
• Schmolke M, Manicassamy B, Pena L et al. Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog2011; 7: e1002186.
   PubMed Web of Science ®Google Scholar
• Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog2007; 3: 1414–1421.
   PubMed Web of Science ®Google Scholar
• Govorkova EA, Ilyushina NA, Boltz DA, Douglas A, Yilmaz N, Webster RG. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother2007; 51: 1414–1424.
   PubMed Web of Science ®Google Scholar
• Nidom CA, Yamada S, Nidom RV et al. Genetic characterization of H5N1 influenza viruses isolated from chickens in Indonesia in 2010. Virus Genes2012; 44: 459–465.
   PubMed Web of Science ®Google Scholar
• Liu J, Xiao H, Lei F et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science2005; 309: 1206.
   PubMed Web of Science ®Google Scholar
• Li Y, Shi J, Zhong G et al. Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009. J Virol2010; 84: 8389–8397.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Ibrahim MS, Ellakany HF et al. Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. PLoS Pathog2011; 7: e1002068.
   PubMed Web of Science ®Google Scholar
• Chen H, Li Y, Li Z et al. Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol2006; 80: 5976–5983.
   PubMed Web of Science ®Google Scholar
• Neumann G, Chen H, Gao GF, Shu Y, Kawaoka Y. H5N1 influenza viruses: outbreaks and biological properties. Cell Res2010; 20: 51–61.
   PubMed Web of Science ®Google Scholar
• Le MT, Wertheim HF, Nguyen HD, et al. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PLoS ONE2008; 3: e3339.
   PubMed Web of Science ®Google Scholar
• Zhou JF, Zou SM, Li Z et al. Identification of dual receptor-binding specific strains of human H5N1 Viruses in China. Biomed Environ Sci2012; 25: 104–108.
   PubMed Web of Science ®Google Scholar
• Chen H, Smith GJ, Li KS et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci USA2006; 103: 2845–2850.
   PubMed Web of Science ®Google Scholar
• Sakoda Y, Ito H, Uchida Y et al. Reintroduction of H5N1 highly pathogenic avian influenza virus by migratory water birds, causing poultry outbreaks in 2010–2011 winter season in Japan. J Gen Virol2012; 93( Pt 3): 541–550.
   PubMed Web of Science ®Google Scholar
• Islam MR, Haque ME, Giasuddin M et al. New introduction of clade 2.3.2.1 avian influenza virus (H5N1) into Bangladesh. Transbound Emerg Dis 2011 Dec 28. doi:10.1111/j.1865–1682.2011.01297.x.
   Web of Science ®Google Scholar
• WHO/FAO/OIE H5N1 Evolution Working Group. FAO-OIE-WHO technical update: current evolution of avian influenza H5N1 viruses. Geneva: WHO, 2012. Available at http://www.who.int/influenza/human_animal_interface/tripartite_notes_H5N1.pdf (accessed 6 June 2012).
   Google Scholar
• Davis CT, Balish AL, O'Neill E et al. Detection and characterization of clade 7 high pathogenicity avian influenza H5N1 viruses in chickens seized at ports of entry and live poultry markets in Vietnam. Avian Dis2010; 54( 1 Suppl): 307–312.
   PubMed Web of Science ®Google Scholar
• Bao Y, Bolotov P, Dernovoy D et al. The influenza virus resource at the National Center for Biotechnology Information. J Virol2008; 82: 596–601.
   PubMed Web of Science ®Google Scholar
• Auewarakul P, Suptawiwat O, Kongchanagul A et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol2007; 81: 9950–9955.
   PubMed Web of Science ®Google Scholar
• Medina RA, Garcia-Sastre A. Influenza A viruses: new research developments. Nat Rev Microbiol2011; 9: 590–603.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhang Y, Shinya K et al. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog2009; 5: e1000709.
   PubMed Web of Science ®Google Scholar
• Stevens J, Blixt O, Chen LM, Donis RO, Paulson JC, Wilson IA. Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol2008; 381: 1382–1394.
   PubMed Web of Science ®Google Scholar
• Yamada S, Suzuki Y, Suzuki T et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature2006; 444: 378–382.
   PubMed Web of Science ®Google Scholar
• Yamada S, Hatta M, Staker BL et al. Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog2010; 6: e1001034.
   PubMed Web of Science ®Google Scholar
• Ungchusak K, Auewarakul P, Dowell SF et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med2005; 352: 333–340.
   PubMed Web of Science ®Google Scholar
• Huai Y, Xiang N, Zhou L et al. Incubation period for human cases of avian influenza A (H5N1) infection, China. Emerg Infect Dis2008; 14: 1819–1821.
   PubMed Web of Science ®Google Scholar
• Yu H, Gao Z, Feng Z et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS ONE2008; 3: e2985.
   PubMed Web of Science ®Google Scholar
• Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature2006; 440: 435–436.
   PubMed Web of Science ®Google Scholar
• Nicholls JM, Chan MC, Chan WY et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med2007; 13: 147–149.
   PubMed Web of Science ®Google Scholar
• van Riel D, den Bakker MA, Leijten LM et al. Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am J Pathol2010; 176: 1614–1618.
   PubMed Web of Science ®Google Scholar
• Shinya K, Hatta M, Yamada S et al. Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol2005; 79: 9926–9932.
   PubMed Web of Science ®Google Scholar
• Chandrasekaran A, Srinivasan A, Raman R et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol2008; 26: 107–113.
   PubMed Web of Science ®Google Scholar
• To KK, Hung IF, Li IW et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis2010; 50: 850–859.
   PubMed Web of Science ®Google Scholar
• Schrauwen EJ, Herfst S, Leijten LM et al. The multi basic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J Virol2012; 86: 3975–3984.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang J, Huang K et al. Systemic infection of avian influenza A virus H5N1 subtype in humans. Hum Pathol2009; 40: 735–739.
   PubMed Web of Science ®Google Scholar
• Gu J, Xie Z, Gao Z et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet2007; 370: 1137–1145.
   PubMed Web of Science ®Google Scholar
• Zhou JJ, Fang DY, Fu J et al. Infection and replication of avian influenza H5N1 virus in an infected human. Virus Genes2009; 39: 76–80.
   PubMed Web of Science ®Google Scholar
• de Jong MD, Bach VC, Phan TQ et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med2005; 352: 686–691.
   PubMed Web of Science ®Google Scholar
• Li IW, Chan KH, To KW et al. Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol2009; 46: 325–330.
   PubMed Web of Science ®Google Scholar
• Shinya K, Makino A, Hatta M et al. Subclinical brain injury caused by H5N1 influenza virus infection. J Virol2011; 85: 5202–5207.
   PubMed Web of Science ®Google Scholar
• Jang H, Boltz D, Sturm-Ramirez K et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci USA2009; 106: 14063–14068.
   PubMed Web of Science ®Google Scholar
• Woo PC, Tung ET, Chan KH, Lau CC, Lau SK, Yuen KY. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis2010; 201: 346–353.
   PubMed Web of Science ®Google Scholar
• Cilloniz C, Shinya K, Peng X et al. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog2009; 5: e1000604.
   PubMed Web of Science ®Google Scholar
• Zeng H, Pappas C, Belser JA et al. Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection. J Virol2012; 86: 667–678.
   PubMed Web of Science ®Google Scholar
• Schmolke M, Viemann D, Roth J, Ludwig S. Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome. J Immunol2009; 183: 5180–5189.
   PubMed Web of Science ®Google Scholar
• Li C, Bankhead A 3rd, Eisfeld AJ et al. Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. J Virol2011; 85: 10955–10967.
   PubMed Web of Science ®Google Scholar
• Ramos I, Bernal-Rubio D, Durham N et al. Effects of receptor binding specificity of avian influenza virus on the human innate immune response. J Virol2011; 85: 4421–4431.
   PubMed Web of Science ®Google Scholar
• Cilloniz C, Pantin-Jackwood MJ, Ni C et al. Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J Virol2010; 84: 7613–7624.
   PubMed Web of Science ®Google Scholar
• Soepandi PZ, Burhan E, Mangunnegoro H et al. Clinical course of avian influenza A(H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005–2008. Chest2010; 138: 665–673.
   PubMed Web of Science ®Google Scholar
• Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis2006; 6: 303–312.
   PubMed Web of Science ®Google Scholar
• To KK, Chan KH, Fung YF, Yuen KY, Ho PL. Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia. Eur Respir J2010; 36: 969–971.
   PubMed Web of Science ®Google Scholar
• de Jong MD, Simmons CP, Thanh TT et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med2006; 12: 1203–1207.
   PubMed Web of Science ®Google Scholar
• Chen H, Wen X, To KK et al. Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J Infect Dis2010; 201: 1517–1521.
   PubMed Web of Science ®Google Scholar
• Zheng B, Chan KH, Zhang AJ et al. D225G mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus enhances virulence in mice. Exp Biol Med (Maywood)2010; 235: 981–988.
   PubMed Web of Science ®Google Scholar
• Zhou J, To KK, Dong H et al. A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection. J Infect Dis2012; 206: 495–503
   PubMed Web of Science ®Google Scholar
• Sakai-Tagawa Y, Ozawa M, Tamura D et al. Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J Clin Microbiol2010; 48: 2872–2877.
   PubMed Web of Science ®Google Scholar
• Chen W, He B, Li C et al. Real-time RT-PCR for H5N1 avian influenza A virus detection. J Med Virol2007; 56( Pt 5): 603–607.
   Google Scholar
• Rowe T, Abernathy RA, Hu-Primmer J et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol1999; 37: 937–943.
   PubMed Web of Science ®Google Scholar
• Buchy P, Vong S, Chu S et al. Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. PLoS ONE2010; 5: e10864.
   PubMed Web of Science ®Google Scholar
• Lan Y, Zhang Y, Dong L et al. A comprehensive surveillance of adamantane resistance among human influenza A virus isolated from mainland China between 1956 and 2009. Antivir Ther2010; 15: 853–859.
   PubMed Web of Science ®Google Scholar
• Cheung CL, Rayner JM, Smith GJ et al. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis2006; 193: 1626–1629.
   PubMed Web of Science ®Google Scholar
• Pielak RM, Schnell JR, Chou JJ. Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc Natl Acad Sci USA2009; 106: 7379–7384.
   PubMed Web of Science ®Google Scholar
• Adisasmito W, Chan PK, Lee N et al. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis2010; 202: 1154–1160.
   PubMed Web of Science ®Google Scholar
• Stittelaar KJ, Tisdale M, van Amerongen G et al. Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques. Antiviral Res2008; 80: 225–228.
   PubMed Web of Science ®Google Scholar
• Kiso M, Kubo S, Ozawa M et al. Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses. PLoS Pathog2010; 6: e1000786.
   PubMed Web of Science ®Google Scholar
• Boltz DA, Ilyushina NA, Arnold CS, Babu YS, Webster RG, Govorkova EA. Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice. Antivir Res2008; 80: 150–157.
   PubMed Web of Science ®Google Scholar
• McKimm-Breschkin JL, Selleck PW, Usman TB, Johnson MA. Reduced sensitivity of influenza A (H5N1) to oseltamivir. Emerg Infect Dis2007; 13: 1354–1357.
   PubMed Web of Science ®Google Scholar
• Naughtin M, Dyason JC, Mardy S, Sorn S, von Itzstein M, Buchy P. Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virus. Antimicrob Agents Chemother2011; 55: 2004–2010.
   PubMed Web of Science ®Google Scholar
• de Jong MD, Tran TT, Truong HK et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med2005; 353: 2667–2672.
   PubMed Web of Science ®Google Scholar
• Kiso M, Ozawa M, Le MT et al. Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus. J Virol2011; 85: 4667–4672.
   PubMed Web of Science ®Google Scholar
• Boltz DA, Douangngeun B, Phommachanh P et al. Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. J Gen Virol2010; 91( Pt 4): 949–959.
   PubMed Web of Science ®Google Scholar
• Collins PJ, Haire LF, Lin YP et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature2008; 453: 1258–1261.
   PubMed Web of Science ®Google Scholar
• Zhao G, Zhong L, Lu X, et al. Characterisation of a highly pathogenic H5N1 clade 2.3.2 influenza virus isolated from swans in Shanghai, China. Virus Genes2012; 44: 55–62.
   PubMed Web of Science ®Google Scholar
• Jefferson T, Jones MA, Doshi P et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev2012; 1: CD008965.
   PubMed Web of Science ®Google Scholar
• Kao RY, Yang D, Lau LS et al. Identification of influenza A nucleoprotein as an antiviral target. Nat Biotechnol2010; 28: 600–605.
   PubMed Web of Science ®Google Scholar
• Kumaki Y, Day CW, Smee DF, Morrey JD, Barnard DL. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections. Antiviral Res2011; 92: 329–340.
   PubMed Web of Science ®Google Scholar
• Kiso M, Takahashi K, Sakai-Tagawa Y et al. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc Natl Acad Sci USA2010; 107: 882–887.
   PubMed Web of Science ®Google Scholar
• Triana-Baltzer GB, Gubareva LV, Klimov AI et al. Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS ONE2009; 4: e7838.
   PubMed Web of Science ®Google Scholar
• Belser JA, Lu X, Szretter KJ et al. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J Infect Dis2007; 196: 1493–1499.
   PubMed Web of Science ®Google Scholar
• Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, Nash AA. A novel family of peptides with potent activity against influenza A viruses. J Gen Virol2012; 93( Pt 5): 980–986.
   PubMed Web of Science ®Google Scholar
• Zheng BJ, Chan KW, Lin YP et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci USA2008; 105: 8091–8096.
   PubMed Web of Science ®Google Scholar
• Henter JI, Chow CB, Leung CW, Lau YL. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet2006; 367: 870–873.
   PubMed Web of Science ®Google Scholar
• Henter JI, Palmkvist-Kaijser K, Holzgraefe B, Bryceson YT, Palmer K. Cytotoxic therapy for severe swine flu A/H1N1. Lancet2010; 376: 2116.
   PubMed Web of Science ®Google Scholar
• Van Hoeven N, Belser JA, Szretter KJ et al. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J Virol2009; 83: 2851–2861.
   PubMed Web of Science ®Google Scholar
• Haasbach E, Pauli EK, Spranger R et al. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. Antiviral Res2011; 91: 304–313.
   PubMed Web of Science ®Google Scholar
• Hung IF, To KK, Lee CK et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis2011; 52: 447–456.
   PubMed Web of Science ®Google Scholar
• Prabhu N, Prabakaran M, Ho HT et al. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J Virol2009; 83: 2553–2562.
   PubMed Web of Science ®Google Scholar
• Yupiana Y, de Vlas SJ, Adnan NM, Richardus JH. Risk factors of poultry outbreaks and human cases of H5N1 avian influenza virus infection in West Java Province, Indonesia. Int J Infect Dis2010; 14: e800–e805.
   PubMed Web of Science ®Google Scholar
• Guan Y, Chen H, Li K et al. A model to control the epidemic of H5N1 influenza at the source. BMC Infect Dis2007; 7: 132.
   PubMed Web of Science ®Google Scholar
• Henning J, Wibawa H, Morton J, Usman TB, Junaidi A, Meers J. Scavenging ducks and transmission of highly pathogenic avian influenza, Java, Indonesia. Emerg Infect Dis2010; 16: 1244–1250.
   PubMed Web of Science ®Google Scholar
• Paul M, Wongnarkpet S, Gasqui P et al. Risk factors for highly pathogenic avian influenza (HPAI) H5N1 infection in backyard chicken farms, Thailand. Acta Trop2011; 118: 209–216.
   PubMed Web of Science ®Google Scholar
• Henning KA, Henning J, Morton J, Long NT, Ha NT, Meers J. Farm- and flock-level risk factors associated with highly pathogenic avian influenza outbreaks on small holder duck and chicken farms in the Mekong Delta of Viet Nam. Prev Vet Med2009; 91: 179–188.
   PubMed Web of Science ®Google Scholar
• Wu WL, Chen Y, Wang P et al. Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol2008; 82: 1798–1807.
   PubMed Web of Science ®Google Scholar
• Normile D. Avian influenza. Warning of H5N1 resurgence surprises community. Science2011; 333: 1369.
   PubMed Web of Science ®Google Scholar
• Sakoda Y, Ito H, Uchida Y et al. Reintroduction of H5N1 highly pathogenic avian influenza virus by migratory water birds, causing poultry outbreaks in the 2010–2011 winter season in Japan. J Gen Virol2012; 93( Pt 3): 541–550.
   PubMed Web of Science ®Google Scholar
• Ehrlich HJ, Muller M, Oh HM et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med2008; 358: 2573–2584.
   PubMed Web of Science ®Google Scholar
• Khurana S, Wu J, Verma N et al. H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans. J Virol2011; 85: 10945–10954.
   PubMed Web of Science ®Google Scholar
• Langley JM, Risi G, Caldwell M et al. Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study. J Infect Dis2011; 203: 1729–1738.
   PubMed Web of Science ®Google Scholar
• Galli G, Hancock K, Hoschler K et al. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc Natl Acad Sci USA2009; 106: 7962–7967.
   PubMed Web of Science ®Google Scholar
• Patel SM, Atmar RL, El Sahly HM, Cate TR, Keitel WA. A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route. Vaccine2010; 28: 3025–3029.
   PubMed Web of Science ®Google Scholar
• Stephenson I, Nicholson KG, Hoschler K et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. N Engl J Med2008; 359: 1631–1633.
   PubMed Web of Science ®Google Scholar
• Lyall J, Irvine RM, Sherman A et al. Suppression of avian influenza transmission in genetically modified chickens. Science2011; 331: 223–226.
   PubMed Web of Science ®Google Scholar
• Steel J, Lowen AC, Mubareka S, Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog2009; 5: e1000252.
   PubMed Web of Science ®Google Scholar
• Belser JA, Katz JM, Tumpey TM. The ferret as a model organism to study influenza A virus infection. Dis Model Mech2011; 4: 575–579.
   PubMed Web of Science ®Google Scholar
• Gustin KM, Belser JA, Wadford DA, et al. Influenza virus aerosol exposure and analytical system for ferrets. Proc Natl Acad Sci USA2011; 108: 8432–8437.
   PubMed Web of Science ®Google Scholar
• Chen LM, Blixt O, Stevens J et al. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology2012; 422: 105–113.
   PubMed Web of Science ®Google Scholar
• Imai M, Watanabe T, Hatta M et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature2012; 486: 420–428.
   PubMed Web of Science ®Google Scholar
• Herfst S, Schrauwen EJ, Linster M et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science2012; 336: 1534–1541.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Public health, influenza experts agree H5N1 research critical, but extend delay. Geneva: WHO, 2012. Available at: http://www.who.int/mediacentre/news/releases/2012/h5n1_research_20120217/en/index.html (accessed 6 June 2012).
   Google Scholar
• Palese P, Wang TT. H5N1 influenza viruses: Facts, not fear. Proc Natl Acad Sci USA2012; 109: 2211–2213.
   PubMed Web of Science ®Google Scholar
• Cohen J, Malakoff D. Avian influenza. On second thought, flu papers get go-ahead. Science2012; 336: 19–20.
   PubMed Web of Science ®Google Scholar
• Enserink M. Infectious diseases. Controversial studies give a deadly flu virus wings. Science2011; 334: 1192–1193.
   PubMed Web of Science ®Google Scholar
• Siegel JD, Rhinehart E, Jackson M, Chiarello L, Practices HCIC. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control2007; 35: S65–S164.
   PubMed Web of Science ®Google Scholar
• Carrel M, Wan XF, Nguyen T, Emch M. Genetic Variation of highly pathogenic H5N1 avian influenza viruses in vietnam shows both species-specific and spatiotemporal associations. Avian Dis2011; 55: 659–666.
   PubMed Web of Science ®Google Scholar
• Fusaro A, Nelson MI, Joannis T et al. Evolutionary dynamics of multiple sublineages of H5N1 influenza viruses in Nigeria from 2006 to 2008. J Virol2010; 84: 3239–3247.
   PubMed Web of Science ®Google Scholar
• Cattoli G, Fusaro A, Monne I et al. Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine2011; 29: 9368–9375.
   PubMed Web of Science ®Google Scholar